201 related articles for article (PubMed ID: 37424037)
1. A PDA-Functionalized 3D Lung Scaffold Bioplatform to Construct Complicated Breast Tumor Microenvironment for Anticancer Drug Screening and Immunotherapy.
Zhang W; Chen Y; Li M; Cao S; Wang N; Zhang Y; Wang Y
Adv Sci (Weinh); 2023 Sep; 10(26):e2302855. PubMed ID: 37424037
[TBL] [Abstract][Full Text] [Related]
2. A novel tissue-engineered 3D tumor model for anti-cancer drug discovery.
Li W; Hu X; Yang S; Wang S; Zhang C; Wang H; Cheng YY; Wang Y; Liu T; Song K
Biofabrication; 2018 Oct; 11(1):015004. PubMed ID: 30229749
[TBL] [Abstract][Full Text] [Related]
3. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
4. Optimized alginate-based 3D printed scaffolds as a model of patient derived breast cancer microenvironments in drug discovery.
Svanström A; Rosendahl J; Salerno S; Leiva MC; Gregersson P; Berglin M; Bogestål Y; Lausmaa J; Oko A; Chinga-Carrasco G; Petronis S; Standoft S; Ståhlberg A; Håkansson J; Landberg G
Biomed Mater; 2021 Jun; 16(4):. PubMed ID: 34030145
[TBL] [Abstract][Full Text] [Related]
5. 3D printing of hydrogel scaffolds for future application in photothermal therapy of breast cancer and tissue repair.
Luo Y; Wei X; Wan Y; Lin X; Wang Z; Huang P
Acta Biomater; 2019 Jul; 92():37-47. PubMed ID: 31108260
[TBL] [Abstract][Full Text] [Related]
6. A Novel 3D in Vitro Tumor Model Based on Silk Fibroin/Chitosan Scaffolds To Mimic the Tumor Microenvironment.
Li J; Zhou Y; Chen W; Yuan Z; You B; Liu Y; Yang S; Li F; Qu C; Zhang X
ACS Appl Mater Interfaces; 2018 Oct; 10(43):36641-36651. PubMed ID: 30360129
[TBL] [Abstract][Full Text] [Related]
7. Bioengineered 3D Scaffolds in Cancer Research: Focus on Epithelial to Mesenchymal Transition and Drug Screening.
Xu X; Tang L
Curr Pharm Des; 2017; 23(11):1710-1720. PubMed ID: 27908265
[TBL] [Abstract][Full Text] [Related]
8. Organotypic slice cultures of pancreatic ductal adenocarcinoma preserve the tumor microenvironment and provide a platform for drug response.
Lim CY; Chang JH; Lee WS; Lee KM; Yoon YC; Kim J; Park IY
Pancreatology; 2018 Dec; 18(8):913-927. PubMed ID: 30292644
[TBL] [Abstract][Full Text] [Related]
9. Polydopamine-coated biomimetic bone scaffolds loaded with exosomes promote osteogenic differentiation of BMSC and bone regeneration.
Zhou Y; Deng G; She H; Bai F; Xiang B; Zhou J; Zhang S
Regen Ther; 2023 Jun; 23():25-36. PubMed ID: 37063095
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer patient-derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments.
Leiva MC; Garre E; Gustafsson A; Svanström A; Bogestål Y; Håkansson J; Ståhlberg A; Landberg G
J Cell Physiol; 2021 Jun; 236(6):4709-4724. PubMed ID: 33368325
[TBL] [Abstract][Full Text] [Related]
11. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
12. Multiple comparisons of three different sources of biomaterials in the application of tumor tissue engineering in vitro and in vivo.
Li W; Hu X; Wang S; Xing Y; Wang H; Nie Y; Liu T; Song K
Int J Biol Macromol; 2019 Jun; 130():166-176. PubMed ID: 30807798
[TBL] [Abstract][Full Text] [Related]
13. Fabrication of 3D calcium-alginate scaffolds for human glioblastoma modeling and anticancer drug response evaluation.
Chaicharoenaudomrung N; Kunhorm P; Promjantuek W; Heebkaew N; Rujanapun N; Noisa P
J Cell Physiol; 2019 Nov; 234(11):20085-20097. PubMed ID: 30945284
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria-Targeting Polydopamine Nanoparticles To Deliver Doxorubicin for Overcoming Drug Resistance.
Li WQ; Wang Z; Hao S; He H; Wan Y; Zhu C; Sun LP; Cheng G; Zheng SY
ACS Appl Mater Interfaces; 2017 May; 9(20):16793-16802. PubMed ID: 28481505
[TBL] [Abstract][Full Text] [Related]
15. The preparation of cell-containing microbubble scaffolds to mimic alveoli structure as a 3D drug-screening system for lung cancer.
Sun YJ; Hsu CH; Ling TY; Liu L; Lin TC; Jakfar S; Young IC; Lin FH
Biofabrication; 2020 Mar; 12(2):025031. PubMed ID: 32084662
[TBL] [Abstract][Full Text] [Related]
16. The Cisplatin, 5-fluorouracil, Irinotecan, and Gemcitabine Treatment in Resistant 2D and 3D Model Triple Negative Breast Cancer Cell Line: ABCG2 Expression Data.
Ata FK; Yalcin S
Anticancer Agents Med Chem; 2022; 22(2):371-377. PubMed ID: 34315389
[TBL] [Abstract][Full Text] [Related]
17. [Non-small cell lung cancer 95D cells co-cultured with 3D-bioprinted scaffold to construct a lung cancer model in vitro].
Mou H; Wang J; Hu H; Xu W; Chen Q
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):736-40. PubMed ID: 26813591
[TBL] [Abstract][Full Text] [Related]
18. Polyurethane scaffold-based 3D lung cancer model recapitulates
Sun L; Wang X; He Y; Chen B; Shan B; Yang J; Wang R; Zeng X; Li J; Tan H; Liang R
Regen Biomater; 2023; 10():rbad091. PubMed ID: 37965109
[TBL] [Abstract][Full Text] [Related]
19. TRAIL-modified, doxorubicin-embedded periodic mesoporous organosilica nanoparticles for targeted drug delivery and efficient antitumor immunotherapy.
Feng X; Li F; Zhang L; Liu W; Wang X; Zhu R; Qiao ZA; Yu B; Yu X
Acta Biomater; 2022 Apr; 143():392-405. PubMed ID: 35259519
[TBL] [Abstract][Full Text] [Related]
20. Blocking LTB
Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
